[Systematic position, variability and antibiotic properties of the producer of antineoplastic antibiotic tavromycetin].
D000190:Actinomyces / Q000145:classification* / Q000378:metabolism; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis / Q000494:pharmacology*; D001407:Bacillus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor; D046508:Culture Techniques; D004926:Escherichia coli / Q000187:drug effects; D056890:Eukaryota / Q000187:drug effects; D016403:Lymphoma, Large B-Cell, Diffuse; D051379:Mice; D009101:Multiple Myeloma; D009374:Neoplasms, Experimental; D013210:Staphylococcus / Q000187:drug effects
D000903:Antibiotics, Antineoplastic
Sistematicheskoe polozhenie, izmenchivost' i antibioticheskie svoĭstva produtsenta protivoopukholevogo antibiotika tavromitsetina.